Clinical Trials · NCT07415954
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 270
- Start date
- Apr 2026
- Locations
- 63 sites, 10 countries
- Primary endpoint
- Change in glycated haemoglobin (HbA1c) (week 16)